Viewing Study NCT06518551


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-01-05 @ 5:55 PM
Study NCT ID: NCT06518551
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2024-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
Sponsor: Omar Nadeem, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module